International Patent: BISPECIFIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD20 AND BCMA

GENEVA, July 18 -- ABELZETA INC. filed a patent application (US2026/010241) for “BISPECIFIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD20 AND BCMA”. With publication no. WO/2026/151675, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 40/31

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....